(Q37810294)

23 August 2017

title

Targeting survivin in cancer: patent review (English)

1 reference

23 August 2017

1

Jagat R Kanwar

1 reference

23 August 2017

Sishir K Kamalapuram

2

1 reference

23 August 2017

Rupinder K Kanwar

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

Expert Opinion on Therapeutic Patents

23 August 2017

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1723-1737

1 reference

Targeting survivin in cancer therapy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Recent advances in anti-survivin treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Survivin: a new target for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Molecular pathways and targets in cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Survivin and IAP proteins in cell-death mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

New wirings in the survivin networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Proliferative and protective effects of SurR9-C84A on differentiated neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2010.533657

10.1517/13543776.2010.533657

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference